Cognitive behavioral therapy and nicotine replacement for smoking cessation in psychiatric outpatients with major depression

Addictive Disorders and their Treatment

Volumn 6, Issue 2, 2007, Pages 67-72

  Hill, Kevin P ^a   Chang, Grace ^b,c  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Cognitive behavioral therapy; Depression; Nicotine replacement therapy; Smoking cessation

Indexed keywords

NICOTINE; RITE AID; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BECK DEPRESSION INVENTORY; CIGARETTE SMOKING; CLINICAL ARTICLE; CLINICAL TRIAL; COGNITIVE THERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEASIBILITY STUDY; FEMALE; HUMAN; INTERMETHOD COMPARISON; MAJOR DEPRESSION; MALE; MENTAL PATIENT; NICOTINE REPLACEMENT THERAPY; OUTCOME ASSESSMENT; OUTPATIENT; PRIORITY JOURNAL; RATING SCALE; SCORING SYSTEM; SMOKING CESSATION; STATISTICAL SIGNIFICANCE; TOBACCO DEPENDENCE; TRANSDERMAL PATCH;

EID: 34249874909     PISSN: 15315754     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.adt.0000210720.18316.6f     Document Type: Article

References (28)

1. Giovino GA, Henningfeld JE, Tomar SC, et al. Epidemiology of tobacco uses and dependence. Epidemiol Rev. 1995;17:48-65.
2. Murray C, Lopez A. The Global Burden of Disease. Geneva: World Health Organization; 1996.
3. Breslau N, Kilbey MM, Andreski P. Nicotine dependence, major depression, and anxiety in young adults. Arch Gen Psychiatry. 1991;48:1069-1074.
4. Kessler R, McGonagle K, Zhao S, et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Arch Gen Psychiatry. 1994;51:8-19.
5. Covey L, Glassman A, Stetner F. Cigarette smoking and major depression. J Addict Dis. 1998;17:35-46.
6. Anda R, Williamson D, Escobedo L, et al. Depression and the dynamics of smoking: a national perspective. JAMA. 1990;264:1541-1545.
7. Rausch J, Nichinson B, Lamke C, et al. Influence of negative affect on smoking cessation treatment outcome: a pilot study. Br J Addict. 1990;85:929-933.
8. Breslau N, Johnson E, Hiripi E, et al. Nicotine dependence in the United States: prevalence, trends, and smoking persistence. Arch Gen Psychiatry. 2001;58:810-816.
9. Covey L, Glassman A, Stetner F. Major depression following smoking cessation. Am J Psychiatry. 1997;154:263-265.
10. Burgess E, Brown R, Kahler C, et al. Patterns of change in depressive symptoms during smoking cessation: who's at risk for relapse? J Consul Clin Psychol. 2002;70:356-361.
11. Lasser K, Boyd JW, Woolhandler S, et al. Smoking and mental illness: a population based prevalence study. JAMA. 2000;284:2606-2610.
12. Jorm AF. Association between smoking and mental disorders: results from an Australian National Prevalence Survey. Aust N Z J Public Health. 1999; 23:245-248.
13. Farrell M, Howes S, Bebbington P, et al. Nicotine, alcohol and drug dependence and psychiatric comorbidity: results of a national household survey. Br J Psychiatry. 2001;179:432-437.
14. Munoz RF, Marin BV, Posner SE, et al. Mood management mail intervention increases abstinence rates for spanish-speaking Latino smokers. Am J Commun Psychol. 1997;25:325-343.
15. Thorsteinsson HS, Gillin JC, Patten CA, et al. The effects of transdermal nicotine therapy for smoking cessation on depressive symptoms in patients with major depression. Neuropsychopharmacology. 2001;24:350-358.
16. Fiore MC, Bailey WC, Cohen SJ, et al. Treating Tobacco Use and Dependence. Rockville, MD: Department of Health and Human Services, Public Health Service; 2000.
17. West R, McNeill A, Raw M. Smoking cessation guidelines for health professionals: an update. Health Education Authority. Thorax. 2000;55: 987-999.
18. Lancaster T, Stead L, Silagy C, et al. Effectiveness of interventions to help people stop smoking: findings from the Cochrane Library. BMJ. 2000; 321:355-358.
19. Chambless DL, Baker MJ, Baucom DH, et al. Update on empirically validated therapies: II. Clin Psychol. 1998;51:3-16.
20. Hughes JR, Goldstein MG, Hurt RD, et al. Recent advances in pharmacotherapy of smoking. JAMA. 1999;281:72-76.
21. Hays JT, Croghan IT, Offord KP, et al. Over-thecounter (OTC) transdermal nicotine patch therapy. J Addict Dis. 1997;16:136.
22. Sonderskov J, Olsen J, Sabroe S, et al. Nicotine patches in smoking cessation. Am J Epidemiol. 1997;145:309-318.
23. First MB, Spitzer RL, Gibbon M, et al. Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version, Patient Edition (SCID-I/P). New York: Biometrics Research, New York State Psychiatric Institute; 2002.
24. Beck AT, Steer RA, Brown GK. Beck Depression Inventory (2nd ed. Manual). San Antonio, TX: Psychological Corporation; 1996.
25. Heatherton TF, Kozlowski LT, Frecker RC. The Fagerstromtest for nicotine dependence: a revision of the Fagerstrom tolerance questionnaire. Br J Addict. 1991;86:1119-1127.
26. Hughes JR, Hatsukami D. Signs and symptoms of tobacco withdrawal. Arch Gen Psychiatry. 1986;43: 289-294.
27. Munoz RF, Organista K, Hall SM. Mood Management Training to Prevent Smoking Relapse: A Cognitive-Behavioral Treatment Manual. San Francisco: Department of Psychiatry, University of California; 1988.
28. SAS [computer program]. Version 9.1. Cary, NC: SAS Institute; 2003.